AI
DFTX

AdvisorShares Investments’s Definium Therapeutics DFTX Stock Holding History

AdvisorShares Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Buy
121,381
+30,080
+33% +$743K 0.69% 27
2026
Q1 		$1.73M Sell
91,301
-11,537
-11% -$196K 0.31% 49
2025
Q4 		$1.38M Sell
102,838
-18,826
-15% -$233K 0.23% 58
2025
Q3 		$1.43M Buy
121,664
+12,071
+11% +$113K 0.23% 51
2025
Q2 		$711K Sell
109,593
-10,000
-8% -$65.8K 0.13% 87
2025
Q1 		$663K Buy
119,593
+15,884
+15% +$114K 0.13% 86
2024
Q4 		$722K Sell
103,709
-5,457
-5% -$37.5K 0.14% 63
2024
Q3 		$621K Sell
109,166
-15,000
-12% -$104K 0.12% 70
2024
Q2 		$878K Buy
124,166
+14,659
+13% +$128K 0.15% 57
2024
Q1 		$1.03M Sell
109,507
-3,267
-3% -$18.6K 0.17% 51
2023
Q4 		$413K Sell
112,774
-4,637
-4% -$14K 0.1% 179
2023
Q3 		$367K Buy
117,411
+26,047
+29% +$107K 0.1% 155
2023
Q2 		$326K Sell
91,364
-1,946
-2% -$6.71K 0.09% 171
2023
Q1 		$296K Sell
93,310
-20,127
-18% -$66.9K 0.09% 168
2022
Q4 		$250K Buy
113,437
+53,485
+89% +$149K 0.07% 206
2022
Q3 		$210K Buy
59,952
+9,942
+20% +$95.4K 0.06% 228
2022
Q2 		$480K Buy
50,010
+6,732
+16% +$85.2K 0.13% 100
2022
Q1 		$721K Buy
43,278
+15,443
+55% +$268K 0.12% 98
2021
Q4 		$576K Buy
27,835
+17,667
+174% +$564K 0.07% 106
2021
Q3 		$355K Buy
10,168
+4,835
+91% +$209K 0.06% 118
2021
Q2 		$276K Buy
+5,333
New +$280K 0.04% 142

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AdvisorShares Investments's DFTX Position: Q2 2026 in Review

AdvisorShares Investments increased its Definium Therapeutics (DFTX) stake by 33% in Q2 2026, buying an estimated $743K and bringing the position to 121,381 shares worth $5.71M. The position accounts for 0.69% of the portfolio, ranked #27.

AdvisorShares Investments first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • AdvisorShares Investments held 121,381 shares of Definium Therapeutics worth $5.71M as of Q2 2026.
  • AdvisorShares Investments bought 30,080 Definium Therapeutics shares in Q2 2026, an estimated $743K.
  • Definium Therapeutics made up 0.69% of AdvisorShares Investments's portfolio in Q2 2026, its #27 holding.
  • AdvisorShares Investments first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.